OTC Field definition

OTC Field means the area of non-prescription (i.e., not requiring, by law or regulation, a prescription from a medical doctor) and/or over-the-counter sales for all human pharmaceutical uses.

Split View

AI-Powered Contracts

Draft, Review & Redline at the Speed of AI

Get StartedSchedule a Demo

OTC Field means the offer for sale or sale of a pharmaceutical product directly to consumers without a prescription from a physician or other healthcare provider with prescribing authority, including pharmaceutical products designated as over-the-counter or behind-the-counter or semi-ethical.

OTC Field means the human field for the over-the-counter/consumer market, which includes any PRODUCT labeled for sale or marketed to a final purchaser of a PRODUCT who purchases the PRODUCT for the purpose of diagnosis of themselves or their family and friends.

Examples of OTC Field in a sentence

• Except for ANDA No. 76-050 and ANDA No. 75-989, WCH shall file, own and maintain all other submissions for Regulatory Approval and Pricing Approval of Products for the OTC Field in the Exclusive Territory.

• WCH shall be responsible for all communications with the FDA and other Regulatory Authorities regarding applications for Regulatory Approval submitted by WCH and post-Regulatory Approval regulatory requirements for Product marketed by WCH for the OTC Field in the Territory, including pharmacovigilance and Adverse Drug Experience reporting, unless otherwise agreed in advance in writing by the Parties.

• During the Term, neither WCH nor its Affiliates shall market, promote, use, distribute, sell, have sold, import, export, make or have made a Competing Product for the OTC Field in the Territory.

• During the Term, IMPAX and its Affiliates shall only sell Product for the OTC Field in the Exclusive Territory to WCH and shall not market, promote, use, distribute, sell, have sold, import, export, make or have made either a twelve-hour or twenty-four hour, extended release Loratadine and Pseudoephedrine combination product (other than the Products) which is, in dosage strength, identical to either Product (a "Competing Product") to a Third Party for the OTC Field in the Exclusive Territory.

• During the Term, IMPAX and its Affiliates shall only sell Product for the OTC Field in the Exclusive Territory to WCH and shall not market, promote, use, distribute, sell, have sold, import, export, make or have made either a twelve-hour or twenty-four hour, extended release Loratadine and Pseudoephedrine combination product (other than the Products) which is, in dosage strength, identical to either Product (a “Competing Product”) to a Third Party for the OTC Field in the Exclusive Territory.

• CIMA and WCH wish to amend the Original Supply Agreement to remove the OTC Field (as defined herein) and to enter into this Supply Agreement which relates only to the OTC Field, all on the terms and subject to the conditions set forth herein.

• In addition to the foregoing, WCH shall have an exclusive license under the CIMA Patents and Technical Information, and CIMA's interest in the Joint Patent Rights, to make (and to have made) Product for the OTC Field in the Territory subject to, and in accordance with, the provisions of Section 11.3(b) and the applicable provisions of the Supply Agreement.

• Subject to Section 2.9, WCH shall exclusively purchase all of WCH's requirements of Product for the OTC Field in the Territory from CIMA and CIMA shall exclusively supply Product for the OTC Field to WCH in the Territory.

• In addition, WCH shall provide CIMA with a non-binding estimate of its annual Net Sales of Product by quarter ninety (90) days prior to the Launch Date of Product in the OTC Field.

• WCH shall be responsible for and shall file, own and maintain all submissions for Regulatory Approval and Regulatory Approvals of Product for the OTC Field in the United States.